MA53324A - Nouvelles particules de support pour formulations de poudre sèche pour inhalation - Google Patents

Nouvelles particules de support pour formulations de poudre sèche pour inhalation

Info

Publication number
MA53324A
MA53324A MA053324A MA53324A MA53324A MA 53324 A MA53324 A MA 53324A MA 053324 A MA053324 A MA 053324A MA 53324 A MA53324 A MA 53324A MA 53324 A MA53324 A MA 53324A
Authority
MA
Morocco
Prior art keywords
dry powder
powder formulations
carrying particles
new carrying
inhalation dry
Prior art date
Application number
MA053324A
Other languages
English (en)
Inventor
Tomaso Guidi
Amrit Paudel
Pinto Joana Filipa Fernandes Teixeira
Sarah Elisabeth Zellnitz
Original Assignee
Chiesi Farm Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farm Spa filed Critical Chiesi Farm Spa
Publication of MA53324A publication Critical patent/MA53324A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
MA053324A 2018-07-27 2019-07-24 Nouvelles particules de support pour formulations de poudre sèche pour inhalation MA53324A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP18186078 2018-07-27

Publications (1)

Publication Number Publication Date
MA53324A true MA53324A (fr) 2021-06-09

Family

ID=63079833

Family Applications (1)

Application Number Title Priority Date Filing Date
MA053324A MA53324A (fr) 2018-07-27 2019-07-24 Nouvelles particules de support pour formulations de poudre sèche pour inhalation

Country Status (12)

Country Link
US (1) US11813360B2 (fr)
EP (1) EP3829641B1 (fr)
JP (1) JP7439084B2 (fr)
KR (1) KR102784384B1 (fr)
CN (1) CN112469443B (fr)
AU (1) AU2019311268B2 (fr)
BR (1) BR112021001402A2 (fr)
ES (1) ES2981460T3 (fr)
MA (1) MA53324A (fr)
MX (1) MX2021000779A (fr)
PL (1) PL3829641T3 (fr)
WO (1) WO2020020957A1 (fr)

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2601973Y2 (ja) 1993-06-17 1999-12-13 積水ハウス株式会社 旗取付具
PE20011227A1 (es) 2000-04-17 2002-01-07 Chiesi Farma Spa Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros
AU2001291721A1 (en) * 2000-08-25 2002-03-04 Merck Patent G.M.B.H Powdered mannitol and mannitol-containing compositions
CA2427991C (fr) * 2000-11-06 2008-01-22 Asahi Kasei Kabushiki Kaisha Particules cellulosiques destinees a des preparations pharmaceutiques
JP2005506956A (ja) * 2001-06-01 2005-03-10 イーライ・リリー・アンド・カンパニー 長時間作用性ｇｌｐ−１製剤
DE60239639D1 (de) 2002-07-31 2011-05-12 Chiesi Farma Spa Pulverinhalator
WO2004073827A1 (fr) 2003-02-21 2004-09-02 The University Of Bath Procede de production de particules
JP2008524317A (ja) * 2004-12-21 2008-07-10 ファイザー・プロダクツ・インク 腸溶コーティングされたアジスロマイシン多粒子
GB0705159D0 (en) 2007-03-19 2007-04-25 Prosonix Ltd Process for making crystals
GB0711680D0 (en) 2007-06-18 2007-07-25 Prosonix Ltd Process
BRPI0912014A2 (pt) * 2008-05-09 2019-03-06 Grünenthal GmbH processo para a preparação de uma formulação em pó intermediária e uma forma de dosagem sólida final sob uso de uma etapa de congelamento por atomização
CN102149437B (zh) 2008-07-18 2017-02-15 普罗索尼克斯有限公司 用于提高氟替卡松颗粒结晶度的方法
EP2216327A1 (fr) 2009-02-06 2010-08-11 CHIESI FARMACEUTICI S.p.A. Benzoate de (1-Phenyl-2-Pyridin-4-yl)ethyle en tant qu'inhibiteurs de phosphodiestérase
CN102811715A (zh) * 2009-12-08 2012-12-05 悉尼大学 可吸入制剂
EP2601973A1 (fr) * 2011-12-09 2013-06-12 Laboratoires SMB SA Formulation de poudre sèche de dérivé d'azole pour inhalation
US9554992B2 (en) * 2014-06-09 2017-01-31 Chiesi Farmaceutici S.P.A. Inhalation particles comprising a combination of an anticholinergic, a corticosteroid and a beta-adrenergic

Also Published As

Publication number Publication date
JP2021531948A (ja) 2021-11-25
AU2019311268A1 (en) 2021-02-11
AU2019311268B2 (en) 2025-01-16
US11813360B2 (en) 2023-11-14
CA3105265A1 (fr) 2020-01-30
MX2021000779A (es) 2021-03-31
US20210290540A1 (en) 2021-09-23
PL3829641T3 (pl) 2024-09-30
KR102784384B1 (ko) 2025-03-21
CN112469443B (zh) 2024-04-16
KR20210040102A (ko) 2021-04-12
EP3829641A1 (fr) 2021-06-09
BR112021001402A2 (pt) 2021-04-27
EP3829641B1 (fr) 2024-05-22
CN112469443A (zh) 2021-03-09
JP7439084B2 (ja) 2024-02-27
WO2020020957A1 (fr) 2020-01-30
ES2981460T3 (es) 2024-10-09

Similar Documents

Publication Publication Date Title
EP3668490A4 (fr) Compositions de poudre sèche pour administration intranasale
IL281930A (en) Rna particles comprising polysarcosin
EP3407870A4 (fr) Inhalateur à poudre sèche
HUE072078T2 (hu) Szilárd részecskéket magába záró hidrogél készítmények
EP3452170A4 (fr) Poudre sèche de tréprostinil pour le traitement de l'hypertension pulmonaire
EP3478264C0 (fr) Particules et compositions de nicotine
EP3862318A4 (fr) Composition de particules de silice poreuse
DK3107548T3 (da) Tørpulverformuleringer til inhalation
FR3003163B1 (fr) Poudre pour cosmetiques et composition cosmetique comprenant celle-ci
MA55629A (fr) Compositions d'anticorps pour le traitement de tumeurs
MA52252A (fr) Formulation de poudre nasale pour le traitement de l'hypoglycémie
DK3325059T3 (da) Tørpulverinhalator
EP3714928A4 (fr) Nouveau dispositif d'inhalation de poudre sèche
EP3478644B8 (fr) Agent de frittage pour composition particulaire sèche
EP3448483A4 (fr) Soufflante pour appareil respiratoire
EP3476382A4 (fr) Agent de traitement de poudre pour cosmétique, poudre pour cosmétique, et cosmétique formulé en utilisant ladite poudre
EP3612173A4 (fr) Formulations pour la pulvérisation d'épinéphrine
PL3541200T3 (pl) Formulacje proszkowe
HUE059584T2 (hu) Gyógyszerészeti készítmény vérszegénység kezelésére
EP3349738A4 (fr) Système et procédé pour réguler l'âpreté de formulations de poudres sèches de nicotine
EP3437623A4 (fr) Poudre de verre pour utilisation dentaire
DK3138600T3 (da) Tørpulverinhalator
EP3487563A4 (fr) Inhalateur à poudre sèche
EP3834042A4 (fr) Particules composites pour additifs d'encre en poudre
EP3327172A4 (fr) Appareil de revêtement de poudre